Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 9 ADMA Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue Estimates
May 9 ETNB 89bio GAAP EPS of -$0.54 misses by $0.07
May 9 ACAD Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
May 9 ADMA ADMA Biologics GAAP EPS of $0.08 beats by $0.02, revenue of $81.9M beats by $4.62M
May 9 ETNB 89bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 9 ADMA ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
May 9 ACAD ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
May 9 AEON AEON Biopharma, Inc. (AEON) Loses -79.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
May 9 AEON AEON Biopharma Provides Update on Development Pipeline
May 9 AADI Aadi Bioscience First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.57 loss in 1Q 2023)
May 9 ACAD ACADIA Pharmaceuticals Inc (ACAD) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue ...
May 9 ACAD ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Call Transcript
May 9 ACAD ACADIA Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation
May 8 ADMA ADMA Biologics Q1 2024 Earnings Preview
May 8 ACAD Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
May 8 ACAD Acadia Pharma GAAP EPS of $0.10 beats by $0.05, revenue of $205.83M misses by $2.75M
May 8 ETNB 89bio to Participate in the BofA Securities 2024 Health Care Conference
May 8 ACAD Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
May 8 AADI Aadi Bioscience, Inc. (AADI) Q1 2024 Earnings Call Transcript
May 8 AADI Aadi Bioscience GAAP EPS of -$0.68 misses by $0.06, revenue of $5.4M misses by $1.29M
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags